A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

Not specified

Study Completion Date

August 31, 1990

Conditions
AIDS Dementia ComplexHIV Infections
Interventions
DRUG

Zidovudine

Trial Locations (21)

10003

Beth Israel Med Ctr / Peter Krueger Clinic, New York

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10021

Mem Sloan - Kettering Cancer Ctr, New York

10029

Mount Sinai Med Ctr, New York

10461

Bronx Municipal Hosp Ctr/Jacobi Med Ctr, The Bronx

10465

Jack Weiler Hosp / Bronx Municipal Hosp, The Bronx

11373

City Hosp Ctr at Elmhurst / Mount Sinai Hosp, Elmhurst

14215

SUNY / Erie County Med Ctr at Buffalo, Buffalo

14642

Univ of Rochester Medical Center, Rochester

21287

Johns Hopkins Hosp, Baltimore

29169

Julio Arroyo, West Columbia

70112

Charity Hosp / Tulane Univ Med School, New Orleans

Louisiana State Univ Med Ctr / Tulane Med School, New Orleans

Tulane Univ School of Medicine, New Orleans

90095

UCLA CARE Ctr, Los Angeles

94305

Stanford Univ School of Medicine, Stanford

98105

Univ of Washington, Seattle

331361013

Univ of Miami School of Medicine, Miami

921036325

Univ of California / San Diego Treatment Ctr, San Diego

02114

Harvard (Massachusetts Gen Hosp), Boston

02215

Beth Israel Deaconess Med Ctr, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH